STOCK TITAN

Niki BioSolutions, Inc. (NIKI) Net Income by Year

NIKI

Niki BioSolutions, Inc. reported a net loss of $1.4M in fiscal year 2025. This represents an increase of 68.1% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Niki BioSolutions, Inc. has filed alongside them.

FY2025 annual
Net Income -$1.4M
YoY +68.1%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

NIKI Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-K
Net Income-$1.4M+68.1%-$4.3M-51.1%-$2.8M+71.2%-$9.8M+60.9%-$25.0M-609.1%$4.9M+124.5%-$20.1M-35.6%-$14.8M

NIKI Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2510-KQ3'2510-QQ2'2510-KQ4'2410-KQ3'2410-QQ2'2410-QQ4'2310-KQ2'2310-QQ4'2210-KQ2'2210-QQ4'2110-KQ2'2110-Q
Net IncomeN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Niki BioSolutions, Inc. financials

Frequently Asked Questions

What was Niki BioSolutions, Inc.'s net income in fiscal year 2025?

Niki BioSolutions, Inc. reported a net loss of $1.4M in fiscal year 2025.

How fast is Niki BioSolutions, Inc.'s net income growing?

Niki BioSolutions, Inc. (NIKI) net income rose by 68.1% year over year, from -$4.3M to -$1.4M in fiscal year 2025.

How has Niki BioSolutions, Inc.'s net income changed over the years?

Across the 8 fiscal years this page covers, Niki BioSolutions, Inc. (NIKI) net income went from -$14.8M in fiscal year 2018 to -$1.4M in fiscal year 2025.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Niki BioSolutions, Inc. (NIKI) reported on that line in every period on record.